Aptar Press Releases

Inhalation Drug Delivery Solutions to be Displayed by Aptar Pharma at CPhI China


Inhalation Drug Delivery Solutions to be Displayed by Aptar Pharma at CPhI China


Aptar_Pharma_Logo150x106

Press Release | Aptar Pharma

MAY 16, 2018

Crystal Lake, Illinois: – Aptar Pharma is pleased to be exhibiting once again at CPhI China 2018, from June 20-22 at the Shanghai New International Exhibition Center, Shanghai, China.

At Booth No. N5F30, we will be introducing new market innovations in inhalation drug delivery for the Chinese market, with our experts on hand to demonstrate the benefits of these exciting respiratory solutions designed to help fight the effects of air pollution.

We will also be showcasing Aptar Pharma’s Bag on Valve (BOV) technology as well as our wide range of advanced preservative-free dispensing systems for dermal, eye care and nasal drug delivery routes, which offer pharmaceutical professionals flexibility and performance when dealing with formulation challenges in the industry today.

An innovation wall at the booth will provide visitors with the opportunity to discover a wide range of Aptar Pharma’s technological innovations, such as PremiumCoat™, the coated stopper that represents a step change in the provision of elastomeric stoppers and offers a reduction in particulates for injectables drug delivery.

Further to exhibiting, we are proud to be hosting a half-day seminar on Friday morning, June 22 from 9.30-11.30am, where two of our Aptar Pharma experts will present the following interactive sessions:

‘Healthy Nose, Healthy Life: A Glance at Global Successful Products for Upper Respiratory Health’ with Guenter Nadler, Director Business Development, Consumer Health Care Division. 9.30-10.30am
‘Say No to Preservatives: Package Innovation for Ophthalmic & Dermal Products’ with Tianjiao Fu, Business Development Manager China, Pharma Sales. 10.30-11.10am
A Q&A session will follow. The seminar will take place at location N8 in Meeting Room D.

To connect with Aptar Pharma and meet our experts, register for CPhI China today: https://registration.n200.com/survey/3o0tmuwtfnigm?cid=pr_VIS_CNV20180110%7C2&actioncode=CPHI1204.

Resources

Click on Inhalation Drug Delivery Solutions to be Displayed by Aptar Pharma at CPhI China for other information.
Click on
Aptar Pharma to contact the company directly.

a1

Supplier Information
Supplier: Aptar Pharma
Address: Aptar Radolfzell GmbH, Oeschlestrasse 54-56, 78315 Radolfzell, Germany
Tel: +49 7732 801 0
Fax: +49 7732 801 226
Website: www.aptar.com


Aptar Pharma to Present Diverse Portfolio of Drug Delivery Solutions at FCE Pharma


Aptar Pharma to Present Diverse Portfolio of Drug Delivery Solutions at FCE Pharma


Aptar_Pharma_Logo150x106

Press Release | Aptar Pharma

MAY 16, 2018

Crystal Lake, Illinois: – Aptar Pharma is pleased to exhibit once again at FCE Pharma, which will be held from May 22-24, 2018 at the São Paulo Expo, São Paulo, Brazil. Aptar Pharma has been a main exhibitor at this major event and looks forward to another successful presence at this year’s show.

At Booth No. H021, our experts will present Aptar Pharma’s diverse portfolio of drug delivery solutions and technology innovations across nasal, pulmonary, eye care, dermal and injectable routes.

A highlight of this year’s showcase will be Aptar Pharma’s Ophthalmic Squeeze Dispenser (OSD). With growing customer interest in the Latin America market for preservative free formulations, our eye care experts will be on hand to highlight the benefits of this multi-dose dispenser for preservative-free ophthalmic preparations. With over 150 references worldwide, the Aptar Pharma Ophthalmic Squeeze Dispenser is the first and only FDA-reviewed preservative free dispensing technology and is suitable for a wide range of viscosities.

With almost 17,000 visitors, FCE is the key pharmaceutical and cosmetics tradeshow in Latin America, and is an annual networking place for all the major players in the pharmaceutical industry.

Aptar Pharma has a strong presence in Latin America, with several offices in Brazil and Argentina, and a fully dedicated manufacturing site in Varela, Argentina.

Be sure to visit Aptar Pharma at Booth No. H021 at FCE Pharma this year. Discover our innovative drug delivery solutions portfolio and see why Aptar Pharma is your trusted partner not only in Latin America, but also worldwide.

About Aptar Pharma

Aptar Pharma is part of AptarGroup, Inc., a leading global supplier of a broad range of innovative dispensing and sealing solutions for the beauty, personal care, home care, prescription drug, consumer health care, injectables, food and beverage markets. AptarGroup is headquartered in Crystal Lake, Illinois, with manufacturing facilities in North America, Europe, Asia and South America.

For more information, visit: www.aptar.com/pharma.

Resources

Click on Aptar Pharma to Present Diverse Portfolio of Drug Delivery Solutions for other information.
Click on
Aptar Pharma to contact the company directly.

Aptar


Supplier Information
Supplier: Aptar Pharma
Address: Aptar Radolfzell GmbH, Oeschlestrasse 54-56, 78315 Radolfzell, Germany
Tel: +49 7732 801 0
Fax: +49 7732 801 226
Website: www.aptar.com


Aptar Pharma to Exhibit Eye Care Packaging Innovations at ARVO Annual Meeting


Aptar Pharma to Exhibit Eye Care Packaging Innovations at ARVO Annual Meeting


Aptar_Pharma_Logo150x106

Press Release | Aptar Pharma

APRIL 24, 2018

Crystal Lake, Illinois: – Aptar Pharma, a leading provider of innovative drug delivery systems, is delighted to be presenting at the ARVO Annual Meeting 2018, taking place on April 29 – May 3 at the Hawaii Convention Center, Honolulu, Hawaii.

ARVO’s annual international conference brings together eye and vision researchers to provide the public, patients and policymakers with insight into how their sight-saving work greatly benefits society.

With over 150 references for both prescription medications and consumer products, Aptar Pharma will exhibit at Booth No. 827, where we will demonstrate our expertise in the field of multi-dose preservative-free packaging for Eye Care to ARVO’s 11,000 expected delegates. There will be a special focus on our versatile Ophthalmic Squeeze Dispenser Technology Platform, which allows for a wide range of configurations and applications, enabling customized solutions for specific ophthalmic formulations. With Aptar Pharma known for creating the first and only FDA-reviewed preservative free dispensing technology, our experts will provide delegates with insight into how we can accelerate customers’ speed-to-market in line with industry standards.

Matthias Birkhoff, Vice President Business Development, Global Market Development Consumer Health Care, Aptar Pharma, will present a talk on May 1 at 1pm entitled ‘Trends and Technologies in Ophthalmic Drug Delivery – Significance of Microbiological Safety and Intuitive Design’. The talk will be held at Booth 1800 in the Exhibit Hall.

To connect with Aptar Pharma and meet our team of experts, register for ARVO today: http://www.arvo.org/annual-meeting/registration2/registration/.

About Aptar Pharma

Aptar Pharma is part of AptarGroup, Inc., a leading global supplier of a broad range of innovative dispensing and sealing solutions for the beauty, personal care, home care, prescription drug, consumer health care, injectables, food and beverage markets. AptarGroup is headquartered in Crystal Lake, Illinois, with manufacturing facilities in North America, Europe, Asia and South America.

For more information, visit: www.aptar.com/pharma.

Resources

Click on Aptar Pharma to Exhibit Eye Care Packaging Innovations for other information.
Click on
Aptar Pharma to contact the company directly.

a1


Supplier Information
Supplier: Aptar Pharma
Address: Aptar Radolfzell GmbH, Oeschlestrasse 54-56, 78315 Radolfzell, Germany
Tel: +49 7732 801 0
Fax: +49 7732 801 226
Website: www.aptar.com


Aptar Pharma Showcases Next Generation of Integrated Connected Devices at RDD


Aptar Pharma Showcases Next Generation of Integrated Connected Devices at RDD


Aptar_Pharma_Logo150x106

Press Release | Aptar Pharma

APRIL 09, 2018

Crystal Lake, Illinois: – Aptar Pharma, a leading global solution provider of innovative drug delivery systems, is pleased to be a Platinum Sponsor at RDD 2018, taking place from April 22 to April 26 at the JW Marriott Starr Pass Resort and Spa, Tucson, Arizona.

The RDD conference series is recognized as one of the premier international meetings in the respiratory field, impacting regulatory and scientific policies worldwide. As part of the Platinum Sponsor Seminars at RDD 2018, Aptar Pharma experts will present a 40-minute talk on the most recent FDA guidance on Combination Products, with a focus on respiratory and nasal drug products. The seminar, entitled “Decoding FDA’s Recent Combination Drug Product Guidance: Applications to DPIs, pMDIs, and Nasal Sprays” will be presented by Badre Hammond, Associate Director, Market Development Aptar Pharma Prescription and Wendy Bolf, Regulatory Affairs

Manager, Aptar Pharma Prescription. This seminar will give insights on optimal approaches to help secure approval in this changing and challenging regulatory landscape and will specifically address the following topics:

  • The Basics – medical device, combination product and packaging components
  • NDA/ANDA submissions: regulatory pathway review for combination products
  • Human Factor studies in the context of combination product
  • Clarify expectations: Sponsor, device supplier and regulators

Aptar Pharma’s Platinum Sponsor Seminar will take place twice on Tuesday, April 24 in Tucson Room I and J, at 8:00 AM and again 8:45 AM, ensuring delegates have the greatest opportunity to attend their preferred time slot.

In addition to presenting at RDD 2018, Aptar Pharma will be hosting an interactive table, located in the Arizona Ballroom, where their team of experts will showcase their innovative range of MDIs, DPIs and BAIs, and demonstrate how they can accelerate speed-to-market by assisting customers from concept through to regulatory submission and approval.

The Aptar Pharma table will also feature a Connectivity Focus, dedicated to the growing field of c-Devices, offering insight into their range of add-on and integrated cDevices. These intuitive devices feature fully-connected functionality and software integration to improve patient health outcomes.

To connect with Aptar Pharma at RDD 2018 and meet their team of experts, register at: http://www.rddonline.com/registration.

About Aptar Pharma

Aptar Pharma is part of AptarGroup, Inc., a leading global supplier of a broad range of innovative dispensing and sealing solutions for the beauty, personal care, home care, prescription drug, consumer health care, injectables, food and beverage markets. AptarGroup is headquartered in Crystal Lake, Illinois, with manufacturing facilities in North America, Europe, Asia and South America.

For more information, visit: www.aptar.com/pharma.

About RDD Online

RDD Online manages the organization of Respiratory Drug Delivery meetings in the US, and partners with Aptar Pharma to run RDD meetings in Europe and Asia.

Other RDD Online services available at www.rddonline.com include the provision of scientific and technical publications, aerosol testing equipment including dose collection tubes and mixing inlets, web-based training, textbook publishing, service directories and recruiting services of interest to companies active in pulmonary and nasal drug delivery. For more information, please visit: www.rddonline.com.

Resources

Click on Aptar Pharma Showcases Connected Devices at RDD for other information.
Click on
Aptar Pharma to contact the company directly.

a1

Supplier Information
Supplier: Aptar Pharma
Address: Aptar Radolfzell GmbH, Oeschlestrasse 54-56, 78315 Radolfzell, Germany
Tel: +49 7732 801 0
Fax: +49 7732 801 226
Website: www.aptar.com


Aptar Pharma Promotes Latest Injectable Developments at PDA Annual Meeting 2018


Aptar Pharma Promotes Latest Injectable Developments at PDA Annual Meeting 2018


Aptar_Pharma_Logo150x106

Press Release | Aptar Pharma

MARCH 15, 2018

Crystal Lake, Illinois: – Aptar Pharma, a leading provider of innovative drug delivery systems, is pleased to once again be an exhibitor at the 2018 PDA Annual Meeting, taking place on March 19-21 in Orlando, Florida.

The 2018 PDA Annual Meeting presents pharma professionals with the opportunity to gain unique insights into industry advancements in processing, manufacturing and quality control, as well as developments for new pharmaceutical and biopharmaceutical products. Delegates also have access to plenary sessions focused on future trends, disruptive technologies and patient centricity.

Aptar Pharma experts will showcase the latest developments in its Premium product portfolio of PremiumFill®, PremiumCoat™ and PremiumVision™ at Stand No. 406, demonstrating its response to the need for higher quality standards within elastomer components.

Additionally, Next Breath, an Aptar Pharma business, will showcase its analytical services. The company has recently expanded to include development services for injectable delivery systems, with a core focus on extractables and leachables profiling. Attendees can learn more about how Next Breath can help to guide them through the quality requirement increases for component qualification, validation and regulatory compliance.

About Aptar Pharma

Aptar Pharma is part of AptarGroup, Inc., a leading global supplier of a broad range of innovative dispensing and sealing solutions for the beauty, personal care, home care, prescription drug, consumer health care, injectables, food and beverage markets. AptarGroup is headquartered in Crystal Lake, Illinois, with manufacturing facilities in North America, Europe, Asia and South America.

For more information, visit: www.aptar.com/pharma.

To connect with Aptar Pharma and meet our team of experts, Register now at 2018 PDA Annual Meeting.

Resources

Click on Aptar Pharma Promotes Latest Injectable Developments for other information.
Click on
Aptar Pharma to contact the company directly.

Doctor giving patient injection in volunteer clinic Doctor giving patient injection in volunteer clinic[/caption]

Supplier Information
Supplier: Aptar Pharma
Address: Aptar Radolfzell GmbH, Oeschlestrasse 54-56, 78315 Radolfzell, Germany
Tel: +49 7732 801 0
Fax: +49 7732 801 226
Website: www.aptar.com


“Digital Healthcare: Are You Ready to Connect?” Educational Webinar hosted by Aptar Pharma


“Digital Healthcare: Are You Ready to Connect?” Educational Webinar hosted by Aptar Pharma


Aptar_Pharma_Logo150x106

Press Release | Aptar Pharma

FEBRUARY 15, 2018

Crystal Lake, Illinois: – On February 22, 2018, Aptar Pharma will host a live educational webinar on the benefits of connected drug delivery devices, with a particular focus on improving patient regimen compliance.

This free interactive webinar is primarily aimed at R&D Managers and Engineers, Brand Marketing Managers, and Device and Packaging Engineers, as well as Product Managers within Pharma companies.

Entitled ‘Digital Healthcare: Are you ready to connect?’, the webinar will be hosted by Sai Shankar, Aptar Pharma’s Director, Global Business Development – Connected Devices at Aptar Pharma. He will offer insight into the benefits that connected health devices can bring to the whole healthcare ecosystem, such as better patient adherence and health outcomes.

Key topics that will be covered include:

  • How to select an intuitive drug delivery system to enable greater patient compliance
  • How to successfully improve patient health outcomes through connected health technology
  • How connected devices benefit each part of the supply chain
  • How connected devices meet regulatory requirements

About Aptar Pharma

Aptar Pharma is part of AptarGroup, Inc., a leading global supplier of a broad range of innovative dispensing and sealing solutions for the beauty, personal care, home care, prescription drug, consumer health care, injectables, food and beverage markets. AptarGroup is headquartered in Crystal Lake, Illinois, with manufacturing facilities in North America, Europe, Asia and South America.

For more information, visit: www.aptar.com/pharma

‘Digital Healthcare: Are you ready to connect?’ takes place at 15.00 GMT on February 22, 2018. Register now by visiting: http://bit.ly/2ASe6Kb

Resources

Click on “Digital Healthcare: Are You Ready to Connect?” for other information.
Click on
Aptar Pharma to contact the company directly.
Click to Register for the webinar.

a1

Supplier Information
Supplier: Aptar Pharma
Address: Aptar Radolfzell GmbH, Oeschlestrasse 54-56, 78315 Radolfzell, Germany
Tel: +49 7732 801 0
Fax: +49 7732 801 226
Website: www.aptar.com


Injectable Extractable and Leachable Services Announced by Next Breath


Injectable Extractable and Leachable Services Announced by Next Breath


Aptar_Pharma_Logo150x106

Press Release | Aptar Pharma

FEBRUARY 02, 2018

Baltimore, Maryland: – Next Breath, a division of AptarGroup, Inc., is pleased to announce the extension of their cGMP
analytical services to include development services for injectable delivery systems, with a core focus on
extractables and leachables (E&L). Next Breath will be highlighting their new services at the upcoming
drug delivery and packaging conference, Pharmapack, held on February 7-8, 2018 in Paris, France.

For over 16 years, Next Breath has offered a wide array of dedicated analytical services for inhalation
and nasal drug development while providing support for global regulatory strategy. This recent addition
of services for injectable delivery comes as a natural extension for the company to support their growing
portfolio of global customers looking for guidance to help them navigate through the increasing quality
expectations for component qualification, validation and regulatory compliance.

As part of these services, Next Breath works with customers to define the characteristics of elastomeric
components that are best suited for their drug product, assess functionality for the intended use,
examine extractables and leachables, and determine physical and chemical compatibility. This
systematic approach makes Next Breath services ideal for identifying potential leachables and meeting
regulatory expectations.

“Next Breath is excited to marry our analytical chemistry capabilities and delivery systems expertise to
service the injectable market ” said Julie Suman, R.Ph., Ph.D., President of Next Breath. “We are in a
unique position to support our clients’ requirements from an extractables profile to toxicological
assessment in this evolving regulatory market.”

“E&L services provided by Next Breath offer an added-value to the Injectables Division which will not
only facilitate component selection but also accelerate regulatory approval,” said Bas van Buijtenen
President, Injectables Division, Aptar Pharma.

To learn more about Next Breath services and how they can help support stability studies, regulatory
approval and post-market approval for injectable delivery systems, visit the Aptar Pharma booth B24-
B26 at Pharmapack or visit their website at: www.nextbreath.net

About Next Breath

Next Breath, a division of AptarGroup, is a full-service cGMP compliant laboratory specializing in
analytical testing of a range of drug delivery systems from early stage to commercialization. Next Breath
provides comprehensive solutions for the product development process from formulation and CMC
support, to finished batch release and post approval stability to regulatory agencies worldwide.
For more information, visit: www.nextbreath.net.

About Aptar Pharma

Aptar Pharma is part of AptarGroup, Inc., a leading global supplier of a broad range of innovative dispensing and sealing solutions for the beauty, personal care, home care, prescription drug, consumer health care, injectables, food and beverage markets. AptarGroup is headquartered in Crystal Lake, Illinois, with manufacturing facilities in North America, Europe, Asia and South America.

For more information, visit: www.aptar.com/pharma

Media Contacts

Tracey Safran
Business Development Manager, Next Breath
Tel: +1 410 455 5904
Email: ctracey.safran@nextbreath.net

Resources

Click on Injectable Extractable and Leachable Services Announced by Next Breath for other information.
Click on
Aptar Pharma to contact the company directly.


Supplier Information
Supplier: Aptar Pharma
Address: Aptar Radolfzell GmbH, Oeschlestrasse 54-56, 78315 Radolfzell, Germany
Tel: +49 7732 801 0
Fax: +49 7732 801 226
Website: www.aptar.com


Aptar Pharma to Exhibit Innovative Drug Delivery Devices at Pharmapack


Aptar Pharma to Exhibit Innovative Drug Delivery Devices at Pharmapack


Aptar_Pharma_Logo150x106

Press Release | Aptar Pharma

JANUARY 24, 2018

Crystal Lake, Illinois: – Aptar Pharma, a leading drug delivery systems provider, will once again be a key exhibitor at Pharmapack 2018, Europe’s dedicated pharmaceutical packaging and drug delivery event, which takes place on February 7-8 at Paris Expo, Porte de Versailles, France.

Aptar Pharma’s booth, located at Hall 7.1, Booth B24/B26, will present their diverse portfolio of drug delivery solutions and will showcase their latest technology innovations. A dedicated connectivity hub will center on the field of connected healthcare solutions, a significant megatrend, which can greatly improve patient behavior and adherence.

Pharmapack provides invaluable insight into the latest trends, developments and regulatory changes impacting the industry, as well as a wide variety of learning opportunities. This year, three of Aptar Pharma’s experts have been selected to share their specialist knowledge during Pharmapack.

Gerallt Williams, Director – Scientific Affairs at Aptar Pharma, will present Opportunities and Challenges of Drug Delivery Via the Nasal Route, on February 8 at 10.00 am in Conference Room 741. Dr. Williams’ talk is part of Conference Session 3: How will New Drug Delivery Solutions Revolutionize Patient Life and Improve Treatment Adherence?

Arnaud Fournier, Senior Business Project Manager – Injectables will present a Learning Lab on February 7 at 11.30 am at Booth H2. His talk, Setting the Standard for Film Coated Stoppers with an Unrivalled Reduction in Particulates will discuss injectable drug trends given today’s stricter regulatory requirements. With more sensitive drugs being developed, Mr. Fournier will share insight into the need for tighter quality standards and coated packaging solutions such as Aptar Pharma’s PremiumCoat™ coated stopper, which offers an unrivalled reduction in particulates.

Sai Shankar, Director Business Development – Connected Devices, will present a Learning Lab entitled Driving Better Patient Outcomes with Connectivity on February 7 at 15.50 at Booth H2. Mr. Shankar will discuss how patient behavior can be changed through connective, intuitive, user-friendly devices, which can significantly increase does adherence and improve patient health outcomes. He will also feature Aptar Pharma’s connected device portfolio which covers Application Fields such as Respiratory and Eye Care.

Aptar Pharma will also be a selected exhibitor on Pharmapack’s guided Innovation Tours on Thursday, February 8, at 10.30am at the Innovation Gallery. The Innovation Tours take visitors on a tour of highlighted exhibitors who have made innovative strides in the industry.

Visit Aptar Pharma during Pharmapack at Hall 7.1, Booth B24/B26, where their team of experts look forward to welcoming their valued customers and partners from around the world and to exchange with key opinion leaders in the industry.

With over 400 exhibitors and more than 5,000 Pharma & drug delivery professionals expected to attend Pharmapack this year, Aptar Pharma welcomes the opportunity to once again be a part of this important industry event.

About Aptar Pharma

Aptar Pharma is part of AptarGroup, Inc., a leading global supplier of a broad range of innovative dispensing and sealing solutions for the beauty, personal care, home care, prescription drug, consumer health care, injectables, food and beverage markets. AptarGroup is headquartered in Crystal Lake, Illinois, with manufacturing facilities in North America, Europe, Asia and South America. For more information, visit: www.aptar.com/pharma

Media Contact

Carolyn Penot, Aptar Pharma
Tel: +33 1 39 17 20 38
Email: carolyn.penot@aptar.com

Resources

Click on Aptar Pharma to Exhibit Innovative Drug Delivery Devices at Pharmapack for other information.
Click on
Aptar Pharma to contact the company directly.


Supplier Information
Supplier: Aptar Pharma
Address: Aptar Radolfzell GmbH, Oeschlestrasse 54-56, 78315 Radolfzell, Germany
Tel: +49 7732 801 0
Fax: +49 7732 801 226
Website: www.aptar.com


AptarGroup, Inc. Awarded Excellence in Pharma Sustainability Initiative at CPhI 2017


AptarGroup, Inc. Awarded Excellence in Pharma Sustainability Initiative at CPhI 2017


Aptar_Pharma_Logo150x106

Press Release | Aptar Pharma

DECEMBER 18, 2017

Crystal Lake, Illinois: – AptarGroup, Inc., a leading global supplier of a broad range of innovative dispensing and sealing solutions for the beauty, personal care, home care, prescription drug, consumer health care, injectables, food and beverage markets, announces that it was awarded the inaugural Excellence in Pharma: Sustainability Initiative of the Year at CPhI Worldwide 2017. The award was presented as part of the CPhI Pharma Awards Gala, which took place Tuesday, October 24 at the Intercontinental Hotel in Frankfurt, Germany.

Established in 2004, the CPhI Pharma Awards are one of the most prestigious recognitions in the Pharmaceutical industry today. This year’s awards included eight new categories to further reflect the industry’s diversity. The Sustainability Initiative of the Year is one of this year’s new categories. There were over 200 entries across the 19 award categories, and finalists for the awards were announced in August 2017.

Aptar was awarded the Excellence in Pharma: Sustainability Award for its Landfill Free Certification program, a global internal certification program which promotes the efficiencies and conservation of natural resources in a manufacturing setting. Facilities that achieve at least a 90 percent reuse and/or recycling threshold are eligible to receive internal Landfill Free Certification. With more than 40% of Aptar’s manufacturing sites already certified through this program. Aptar has achieved significant accomplishments in waste reduction, cost savings and employee engagement. The program is incorporated as a measurable aspect of Aptar‘s global sustainability strategy and Aptar anticipates more facilities will achieve certification in years to come.

Data from Aptar’s recent customer satisfaction surveys demonstrated the growing importance of sustainability to customers and supply partners. Therefore, Aptar’s internal program further reinforces that Aptar is prioritizing the needs of its customers in line with its own company mission and corporate social responsibility.

Yann Ghafourzadeh, VP, Sales & Operations Europe – Prescription Division, comments, “We are delighted to have been awarded the Sustainability Initiative of the Year at the CPhI Pharma Awards. It is great to be recognised for the progression of Aptar’s Landfill Free Certification program, which has been significant within our global sustainability strategy. We have aligned our program with our customers‘ requirements and we are dedicated to responding to what sustainability considerations are important to them. We look forward to further Aptar facilities obtaining the internal Landfill Free Certification in the future.”

Aptar Pharma, a leading provider of drug delivery devices, components and services for the Pharma industry, is one of Aptar Group’s segments. Aptar Pharma was a main exhibitor at CPhI Worldwide 2017, which took place in Frankfurt, Germany from October 24 – 26. For several years, Aptar Pharma has had a significant presence at this major event in the pharmaceutical industry attended by over 42,000 Pharma professionals.

About Aptar Pharma

Aptar Pharma is part of AptarGroup, Inc., a leading global supplier of a broad range of innovative dispensing and sealing solutions for the beauty, personal care, home care, prescription drug, consumer health care, injectables, food and beverage markets. AptarGroup is headquartered in Crystal Lake, Illinois, with manufacturing facilities in North America, Europe, Asia and South America. For more information, visit: www.aptar.com/pharma

Media Contact

Carolyn Penot, Aptar Pharma
Tel: +33 1 39 17 20 38
Email: carolyn.penot@aptar.com

Resources

Click on AptarGroup, Inc. Awarded Excellence in Pharma Sustainability for other information.
Click on
Aptar Pharma to contact the company directly.

A1

Courtesy of Aptar

Courtesy of Aptar


Supplier Information
Supplier: Aptar Pharma
Address: Aptar Radolfzell GmbH, Oeschlestrasse 54-56, 78315 Radolfzell, Germany
Tel: +49 7732 801 0
Fax: +49 7732 801 226
Website: www.aptar.com


Connected Health Innovations showcased by Aptar Pharma at DDL 2017


Connected Health Innovations showcased by Aptar Pharma at DDL 2017


Aptar_Pharma_Logo150x106

Press Release | Aptar Pharma

NOVEMBER 30, 2017

Crystal Lake, Illinois: – Aptar Pharma, a leading drug delivery systems provider, will exhibit its broad respiratory portfolio at the annual DDL Conference 2017.

DDL 2017 takes place from December 6-8 in Edinburgh, Scotland, and is a renowned conference for scientists, academics, clinicians, regulatory and industry specialists involved in the development of inhalation medicines.

Aptar Pharma is a worldwide leader in respiratory drug delivery devices for treatment of asthma and COPD. Their team of experts will showcase their innovative range of MDIs, DPIs and BAIs at the conference, and demonstrate how they can accelerate speed-to-market by assisting customers from concept through to regulatory submission.

Aptar Pharma’s exhibition stand will also feature a dedicated Connectivity Hub, supporting the growing field of c-Devices (connected devices), providing insight into its range of add-on and integrated c-Devices. These intuitive devices feature fully-connected functionality and software integration, to improve patient health outcome.

Chris Baron, Associate Director of Business Development at Aptar Pharma, comments “As a leader in inhalation drug delivery systems, we are delighted to be showcasing our connected, intuitive and user-friendly devices at DDL 2017. At Aptar Pharma we strongly believe that the use of connected devices can help change patient behavior, which will result in improved medication management and health outcomes. We are dedicated to supporting customers and patients to effectively treat respiratory diseases such as asthma and COPD, and are proud to have established several digital health solution partnerships to develop a portfolio of c-Devices such as c-MDIs and c-DPIs.”

About Aptar Pharma

Aptar Pharma is part of AptarGroup, Inc., a leading global supplier of a broad range of innovative dispensing and sealing solutions for the beauty, personal care, home care, prescription drug, consumer health care, injectables, food and beverage markets. AptarGroup is headquartered in Crystal Lake, Illinois, with manufacturing facilities in North America, Europe, Asia and South America. For more information, visit: www.aptar.com/pharma

Media Contact

Carolyn Penot, Aptar Pharma
Tel: +33 1 39 17 20 38
Email: carolyn.penot@aptar.com

OR

Olivia Miller, Realia Marketing
Tel: +44(0)1303 262101
Email: olivia.miller@realia.co@realia.co

Resources

Click on Connected Health Innovations showcased by Aptar Pharma at DDL 2017 for other information.
Click on
Aptar Pharma to contact the company directly.


Supplier Information
Supplier: Aptar Pharma
Address: Aptar Radolfzell GmbH, Oeschlestrasse 54-56, 78315 Radolfzell, Germany
Tel: +49 7732 801 0
Fax: +49 7732 801 226
Website: www.aptar.com


Aptar Pharma to Highlight Megatrends in Drug Delivery at CPHI India


Aptar Pharma to Highlight Megatrends in Drug Delivery at CPHI India


Aptar_Pharma_Logo150x106

Press Release | Aptar Pharma

NOVEMBER 27, 2017

Crystal Lake, Illinois: – Aptar Pharma, a leading drug delivery systems provider, is pleased to be an exhibitor once again at CPhI India 2017, which takes place at the Bombay Exhibition Centre (BEC), Mumbai, India from November 28 – 30. For the past number of years, Aptar Pharma has had a significant presence at this major event in the pharmaceutical industry in the Asian region.

This year, the Aptar Pharma booth, located at stand No. H77, Hall 1, will showcase Aptar Pharma’s wide product portfolio covering various routes of administration, including Connected Device Systems for better patient adherence and compliance.

A dedicated innovation area will feature the megatrends that are currently influencing the drug delivery industry.

Driving Better Patient Adherence with Connectivity

Further to exhibiting at CPhI India, Aptar Pharma will present a pharma talk focused on connected healthcare solutions, one such growing megatrend.

Presented by Sai Shankar, Director Business Development – Connected Devices, Aptar Pharma’s Exhibitor Showcase will reveal the findings of a recent study on its integrated connected pMDI. He will also present the company’s connected health devices portfolio that supports respiratory treatment for patients.

Using a patient-centric design approach, Aptar Pharma supports Pharma companies worldwide with custom-made solutions, including connected technologies, for the treatment of respiratory diseases including asthma and COPD.

Sai Shankar’s Exhibitor Showcase will take place on Tuesday, November 28 from 13:00 – 13.45 at Hall 7A, Goregaon.

Join Aptar Pharma at booth No. 77, Hall 1, where their team of experts will be pleased to provide an overview of their wide product portfolio that offers innovative drug delivery systems, components and services covering a broad range of delivery routes.

About Aptar Pharma

Aptar Pharma is part of AptarGroup, Inc., a leading global supplier of a broad range of innovative dispensing and sealing solutions for the beauty, personal care, home care, prescription drug, consumer health care, injectables, food and beverage markets. AptarGroup is headquartered in Crystal Lake, Illinois, with manufacturing facilities in North America, Europe, Asia and South America. For more information, visit: www.aptar.com/pharma

Media Contact

Carolyn Penot, Aptar Pharma
Tel: +33 1 39 17 20 38
Email: carolyn.penot@aptar.com

OR

Livi Webb, Realia Marketing
Tel: +44 (0)1303 262101
Email: livi.webb@realia.co

Resources

Click on Aptar Pharma to Highlight Megatrends in Drug Delivery at CPHI India for other information.
Click on
Aptar Pharma to contact the company directly.

Courtesy of Aptar Pharma Sai Shankar, Director Business Development– Connected Devices

Courtesy of Aptar Pharma
Sai Shankar, Director Business Development – Connected Devices


Supplier Information
Supplier: Aptar Pharma
Address: Aptar Radolfzell GmbH, Oeschlestrasse 54-56, 78315 Radolfzell, Germany
Tel: +49 7732 801 0
Fax: +49 7732 801 226
Website: www.aptar.com


Optimizing Patient Adherence and Compliance in Eye Care – Join Aptar Pharma’s Educational Webinar


Optimizing Patient Adherence and Compliance in Eye Care – Join Aptar Pharma’s Educational Webinar


Aptar_Pharma_Logo150x106

Press Release | Aptar Pharma

NOVEMBER 20, 2017

Crystal Lake, Illinois: – On Tuesday, November 21 at 16:00 CET (10:00 EST), Aptar Pharma will present innovative solutions for better patient adherence in ophthalmic drug delivery during an educational webinar entitled “Optimizing Patient Adherence and Compliance in Eye Care.”

Register now: www.business-review-webinars.com

During this informative webinar, Aptar Pharma experts Matthias Birkhoff and Dr. Degenhard Marx will discuss in detail the importance of microbiological safety for preservative-free Eye Care applications and how reliable drug delivery systems help meet Regulatory requirements.

Although the topical application of ophthalmic drugs is relatively uncomplicated, poor patient dosing regimen compliance remains high and can impede effective treatments. Failure to adhere to proper treatment can have devastating consequences, such as disease progression and visual loss. Furthermore, preservatives added to the medication can also cause problems for the patient.

This webinar will look at current options within the field of preservative-free systems for multidose applications that address these issues, and will discuss industry trends such as Connected Eye Care that will help to increase the level of patient compliance through better patient monitoring.

Register now to learn more about how to improve patient adherence with Eye Care medications and how to choose a packaging format that successfully meets Regulatory authorities’ requirements.

About Aptar Pharma

Aptar Pharma is part of AptarGroup, Inc., a leading global supplier of a broad range of innovative dispensing and sealing solutions for the beauty, personal care, home care, prescription drug, consumer health care, injectables, food and beverage markets. AptarGroup is headquartered in Crystal Lake, Illinois, with manufacturing facilities in North America, Europe, Asia and South America. For more information, visit: www.aptar.com/pharma

Media Contact

Carolyn Penot, Aptar Pharma
Tel: +33 1 39 17 20 38
Email: carolyn.penot@aptar.com

OR

Marion Baschet Vernet, Press Attaché
Tel: +33 6 22 17 08 96
Email: mbvernet@gmail.com

Resources

Click on Optimizing Patient Adherence and Compliance in Eye Care for other information.
Click on
Aptar Pharma to contact the company directly.
Click Optimizing Patient Adherence Webinar to join Aptar Pharma’s educational webinar.


Supplier Information
Supplier: Aptar Pharma
Address: Aptar Radolfzell GmbH, Oeschlestrasse 54-56, 78315 Radolfzell, Germany
Tel: +49 7732 801 0
Fax: +49 7732 801 226
Website: www.aptar.com


Aptar Pharma to Highlight Key Innovations in Drug Delivery at CPHI


Aptar Pharma to Highlight Key Innovations in Drug Delivery at CPHI


Aptar_Pharma_Logo150x106

Press Release | Aptar Pharma

OCTOBER 17, 2017

Crystal Lake, Illinois: – Aptar Pharma, a leading drug delivery systems provider, is pleased to once again be a main exhibitor at CPhI Worldwide 2017, which takes place in Frankfurt, Germany from October 24 – 26. For many years, Aptar Pharma has had a significant presence at this major event in the pharmaceutical industry.

This year, the Aptar Pharma booth, located at stand No. 42F10, Hall 4.2., will feature an innovation area showcasing seven healthcare technology megatrends, including a special connectivity hub, which will be dedicated to the growing field of connected healthcare solutions.

In addition to exhibiting at CPhI Worldwide, Aptar Pharma will present three Pharma Insight Briefings that will highlight its latest innovations and developments in the following drug delivery system areas:

Innovative Respiratory Solutions for Expanding Your Product Portfolio

Guenter Nadler, Director Business Development at Aptar Pharma, will deliver an insightful talk on innovative respiratory solutions on the first day of CPhI Worldwide. As a global rise in allergies and air pollution have led to a significant increase in upper respiratory tract diseases, typical over-the-counter medications and household remedies cannot always fulfil the needs of today’s on-the-go lifestyle.

As one of the leading drug delivery system providers for the development of dispensing solutions for pharmaceutical cough and cold applications, Aptar Pharma’s proven nasal spray and Bag on Valve systems have become the treatment standard in the industry. During the talk, attendees will learn more about how these systems meet today’s requirements for compliant patient treatment.

Guenter Nadler’s Pharma Insight Briefing will take place on Tuesday, October 24 at 10:30 at the Innopack Zone, G1A3.

Driving Better Patient Outcomes with Connectivity

Sai Shankar, Director Business Development – Connected Devices, will present Aptar Pharma’s second Pharma Insight Briefing at CPhI Worldwide.

Using a patient-centric design approach, Aptar Pharma supports Pharma companies worldwide with custom-made solutions, including connected technologies, for the treatment of respiratory diseases including asthma and COPD. The findings of a study recently conducted by Aptar Pharma on its integrated connected pMDI, as well as the company’s connected health devices portfolio that support respiratory treatment for patients, will be among the topics presented at this briefing.

Sai Shankar’s Pharma Insight Briefing will take place on Tuesday, October 24 at 15:50 at the Innopack Zone, G1A3.

Setting New Standards for Coated Stoppers

Arnaud Fournier, Senior Business Project Manager for Injectables at Aptar Pharma, will exclusively introduce PremiumCoat™, a coated stopper which represents a step change in the provision of elastomeric stoppers with a market leading reduction in particulates, and is Aptar Pharma’s response to the growing challenges to developing more sensitive drugs in the pharmaceutical market.

Arnaud Fournier’s Pharma Insight Briefing on the latest development in Aptar Pharma’s Premium Injectables portfolio will take place on Wednesday, October 25 at 10:30 at the Innopack Zone, G1A3.

With over 42,000 Pharma professionals attending CPhI Worldwide every year, Aptar Pharma welcomes the opportunity to meet with their valued customers and business partners, exchange with key opinion leaders in the Pharma industry and showcase their latest key innovations.

Join Aptar Pharma at booth No. 42F10, Hall 4.2, where their team of experts will be pleased to give an overview of their wide product portfolio that provides innovative drug delivery systems, components and services covering a broad range of delivery routes.

About Aptar Pharma

Aptar Pharma is part of AptarGroup, Inc., a leading global supplier of a broad range of innovative dispensing and sealing solutions for the beauty, personal care, home care, prescription drug, consumer health care, injectables, food and beverage markets. AptarGroup is headquartered in Crystal Lake, Illinois, with manufacturing facilities in North America, Europe, Asia and South America. For more information, visit www.aptar.com//pharma

Media Contact

Carolyn Penot, Aptar Pharma
Tel: +33 1 39 17 20 38
Email: carolyn.penot@aptar.com

OR

Marion Baschet Vernet, Press Attaché
Tel: +33 6 22 17 08 96
Email: mbvernet@gmail.com

Resources

Click on Aptar Pharma to Highlight Key Innovations in Drug Delivery at CPHI for other information.
Click on
Aptar Pharma to contact the company directly.

Courtesy of Aptar Pharma, Guenter Nadler, Director Business Development

Courtesy of Aptar Pharma, Guenter Nadler, Director Business Development

Courtesy of Aptar Pharma, Sai Shankar, Director Business Development– Connected Devices

Courtesy of Aptar Pharma, Sai Shankar, Director Business Development– Connected Devices

Courtesy of Aptar Pharma, Arnaud Fournier, Senior Business Project Manager, Injectables

Courtesy of Aptar Pharma, Arnaud Fournier, Senior Business Project Manager, Injectables


Supplier Information
Supplier: Aptar Pharma
Address: Aptar Radolfzell GmbH, Oeschlestrasse 54-56, 78315 Radolfzell, Germany
Tel: +49 7732 801 0
Fax: +49 7732 801 226
Website: www.aptar.com